$SPPI Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated NonSmall Cell Lung Cancer Patients with Exon 20 Insertion Mutations. Results 2H 2019

$SPPI Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations. Results 2H 2019

07:01 EST 2 Jan 2019 | Odi Bruckman

$SPPI Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations. Results 2H 2019

More From BioPortfolio on "$SPPI Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations. Results 2H 2019"